Market Is Estimated To Witness High Growth Owing To Growing Demand For Personalized Medicine & Advancements In AI and Genomics Technologies
Artificial Intelligence In Digital Genome Market |
The Artificial Intelligence In Digital Genome Market is
estimated to be valued at US$ 269.8
million in 2023 and is expected to exhibit a CAGR of 44.8% over the forecast period of 2023-2028, as highlighted
in a new report published by Coherent Market Insights.
Market Overview:
Artificial intelligence facilitates the analysis of genomic data and helps
discover meaningful patterns for disease diagnosis and drug development. AI in
genomics is used for various applications such as genome analysis, precision
medicine, non-invasive prenatal testing, and drug discovery. It aids in the
detection of genetic variants, identification of disease-causing genes, and
helps predict disease risks and drug responses at an individual level with high
accuracy.
Market Dynamics:
Growing demand for personalized medicine: Advances in genomics and artificial
intelligence have enabled the discovery of genetic basis of diseases and
development of personalized treatment plans. AI aids in analyzing massive
amounts of genomic and clinical data to provide tailored treatment and care
based on an individual's genetic profile. This is expected to drive the demand
for AI in digital genome solutions over the forecast period.
Advancements in AI and genomics technologies: Continuous technological
advancements are improving computational capabilities for analyzing large
genomic datasets. Developments in areas such as machine learning, deep
learning, and cloud computing are making AI more efficient and scalable for
precision medicine applications. Moreover, next-generation sequencing
technologies are making whole genome sequencing affordable and widely
accessible. These technological developments are supporting the integration of
AI and genomics.
SWOT Analysis:
Strength: Artificial intelligence in digital genome has the potential to
improve healthcare outcomes and transform drug discovery. AI can analyze
massive genomic datasets and medical records faster than humans. It allows to
identify new genetic targets and speed up researchers.
Weakness: Lack of skilled workforce and high investment requirements are major
challenges for the growth of artificial intelligence in digital genome market.
Data privacy and security concerns also limit the widespread adoption of these
technologies.
Opportunity: Growing genomics market andincreasing funding for genomic research
presents huge opportunities for AI tools providers. Developing economies also
offer scope of growth due to rising healthcare expenditures.
Threats: Slow regulatory approvals and reluctance among physicians to adopt new
technologies are major threats. Ethical issues related to genomics data use can
limit collaborations between companies.
Key Takeaways
The Global
Artificial Intelligence In Digital Genome Market is expected to witness
high growth, exhibiting CAGR of 44.8%
over the forecast period, due to increasing funding for genomic research and
drug discovery. North America dominates the market currently due growing
genomics industry in the US.
Regional analysis:
North America is expected to dominate the artificial intelligence in digital
genome market during the forecast period. Presence of leading players and
growing genomics research drives the regional market. The US contributes
significantly owing to increasing R&D investments. Asia Pacific shows high
growth potential with expanding healthcare infrastructure in countries like
China and India.
Key players related content:
Key players operating in the artificial intelligence in digital genome market
are NVIDIA Corporation, IBM, Microsoft, Fabric Genomics Inc., Verge Genomics,
MolecularMatch Inc., SOPHiA GENETICS, PrecisionLife Ltd, BenevolentAI, and Deep
Genomics. NVIDIA provides GPUs and AI platforms used by genome analysis
companies. IBM is working on clinical genomics projects using AI and cloud.
Read More - https://www.dailyprbulletin.com/the-future-of-digital-genome-mapping-demand-size/
Comments
Post a Comment